Download biomedica product listDid you know that levels of NT-proANP might affect metabolic syndrome (MetS) differently in men and women?
Atrial natriuretic peptide (ANP) plays a key role in human metabolism and cardiometabolic disorders. Metabolic syndrome (MetS), a combination of obesity with other disease states of homeostasis of fats, sugars and proteins in the body, increases the risk of developing cardiovascular diseases and diabetes. In a study by Guo et al. NT-proANP had a protective effect against MetS in men. Men with high levels of NT-proANP had 0.60 times the risk of having MetS compared with men with low levels of NT-proANP. By contrast, women in the upper NT-proANP quartile group had 1.10 times the risk of having MetS compared to the lower quartile group. This suggests that NT-proANP may affect MetS differently in men and women.
Learn more at: Gender difference of association between plasma N-terminal pro-atrial natriuretic peptide and metabolic syndrome https://bit.ly/2RsHeCy
And check out the Biomedica NT-proANP ELISA:
• CE marked – for IVD use in the EU
• Small sample volume – 10 µl / well
• Assay suitable for rat/mouse samples – NT-proANP as a cardiovascular safety biomarker in rats